Prof. Dr Gisbert Schneider is Professor of Computer-Assisted Drug Design at the Institute of Pharmaceutical Sciences at ETH Zurich and Director of the Singapore-ETH Centre.
The biochemist and bioinformatician has broken new ground and advanced artificial intelligence (AI) to the point that it is now possible to reliably predict the efficacy of drugs. Gisbert Schneider is a pioneer in the field of AI-supported drug development enabled the transfer to industrial application through his visionary research. Today, potential active substances are identified more quickly worldwide and examined for potential side effects.
Gisbert Schneider will receive the Ernst Schering Prize 2022 for his outstanding research in the field of molecular design, in particular the development of machine learning methods to predict the activity of pharmacological agents.
